Literature DB >> 25620546

Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.

Denis A Akkad1, Barbara Bellenberg, Sarika Esser, Florian Weiler, Jörg T Epplen, Ralf Gold, Carsten Lukas, Aiden Haghikia.   

Abstract

Genome-wide association studies (GWAS) underscore the genetic basis of multiple sclerosis (MS); however, only few of the newly reported genetic variations relevant in MS have been replicated or correlated for clinical/paraclinical phenotypes such as spinal cord atrophy in independent patient cohorts. We genotyped 141 MS patients for 58 variations reported to reach significance in GWAS. Expanded disability status scale (EDSS) and disease duration (DD) are available from regular clinical examinations. MRI included sagittal high-resolution 3D T1-weighted magnetization-prepared rapid acquisition gradient echo of the cervical cord region used for volumetry. Due dependency of mean upper cervical cord area (MUCCA) with EDSS and/or DD, correction operations were performed compensating for EDSS/DD. We assessed each MS risk locus for possible MUCCA association. We identified twelve risk loci that significantly correlated with MUCCA. For nine loci-BATF, CYP27B1, IL12B, NFKB1, IL7, PLEK, EVI5, TAGAP and nrs669607-patients revealed significantly higher degree of atrophy; TYK2, RGS1 and CLEC16A revealed inverse effects. The weighted genetic risk score over the twelve loci showed significant correlation with MUCCA. Our data reveal a risk gene depending paraclinical/clinical phenotype. Since MUCCA clearly correlates with disability, the candidates identified here may serve as prognostic markers for disability progression.

Entities:  

Mesh:

Year:  2015        PMID: 25620546     DOI: 10.1007/s10048-015-0438-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  19 in total

1.  Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.

Authors:  Philip L De Jager; Lori B Chibnik; Jing Cui; Joachim Reischl; Stephan Lehr; K Claire Simon; Cristin Aubin; David Bauer; Jürgen F Heubach; Rupert Sandbrink; Michaela Tyblova; Petra Lelkova; Eva Havrdova; Christoph Pohl; Dana Horakova; Alberto Ascherio; David A Hafler; Elizabeth W Karlson
Journal:  Lancet Neurol       Date:  2009-10-29       Impact factor: 44.182

2.  A multicenter assessment of cervical cord atrophy among MS clinical phenotypes.

Authors:  M A Rocca; M A Horsfield; S Sala; M Copetti; P Valsasina; S Mesaros; V Martinelli; D Caputo; T Stosic-Opincal; J Drulovic; G Comi; M Filippi
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

3.  Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.

Authors:  Carsten Lukas; Dirk L Knol; Madeleine H Sombekke; Barbara Bellenberg; Horst K Hahn; Veronica Popescu; Katrin Weier; Ernst W Radue; Achim Gass; Ludwig Kappos; Yvonne Naegelin; Bernard M J Uitdehaag; Jeroen J G Geurts; Frederik Barkhof; Hugo Vrenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-06-27       Impact factor: 10.154

4.  Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

Authors:  Christina M Lill; Tian Liu; Brit-Maren M Schjeide; Johannes T Roehr; Denis A Akkad; Vincent Damotte; Antonio Alcina; Miguel A Ortiz; Rafa Arroyo; Aitzkoa Lopez de Lapuente; Paul Blaschke; Alexander Winkelmann; Lisa-Ann Gerdes; Felix Luessi; Oscar Fernadez; Guillermo Izquierdo; Alfredo Antigüedad; Sabine Hoffjan; Isabelle Cournu-Rebeix; Silvana Gromöller; Hans Faber; Maria Liebsch; Esther Meissner; Coralie Chanvillard; Emmanuel Touze; Fernando Pico; Philippe Corcia; Thomas Dörner; Elisabeth Steinhagen-Thiessen; Lars Baeckman; Hauke R Heekeren; Shu-Chen Li; Ulman Lindenberger; Andrew Chan; Hans-Peter Hartung; Orhan Aktas; Peter Lohse; Tania Kümpfel; Christian Kubisch; Joerg T Epplen; Uwe K Zettl; Bertrand Fontaine; Koen Vandenbroeck; Fuencisla Matesanz; Elena Urcelay; Lars Bertram; Frauke Zipp
Journal:  J Med Genet       Date:  2012-09       Impact factor: 6.318

5.  The CYP27B1 variant associated with an increased risk of autoimmune disease is underexpressed in tolerizing dendritic cells.

Authors:  Fernando Shahijanian; Grant P Parnell; Fiona C McKay; Prudence N Gatt; Maryam Shojoei; Kate S O'Connor; Stephen D Schibeci; Fabienne Brilot; Christopher Liddle; Marcel Batten; Graeme J Stewart; David R Booth
Journal:  Hum Mol Genet       Date:  2013-10-24       Impact factor: 6.150

6.  Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Authors:  R H S R Roxburgh; S R Seaman; T Masterman; A E Hensiek; S J Sawcer; S Vukusic; I Achiti; C Confavreux; M Coustans; E le Page; G Edan; G V McDonnell; S Hawkins; M Trojano; M Liguori; E Cocco; M G Marrosu; F Tesser; M A Leone; A Weber; F Zipp; B Miterski; J T Epplen; A Oturai; P Soelberg Sørensen; E G Celius; N Téllez Lara; X Montalban; P Villoslada; A M Silva; M Marta; I Leite; B Dubois; J Rubio; H Butzkueven; T Kilpatrick; M P Mycko; K W Selmaj; M E Rio; M Sá; G Salemi; G Savettieri; J Hillert; D A S Compston
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Authors:  B C Healy; M Liguori; D Tran; T Chitnis; B Glanz; C Wolfish; S Gauthier; G Buckle; M Houtchens; L Stazzone; S Khoury; R Hartzmann; M Fernandez-Vina; D A Hafler; H L Weiner; C R G Guttmann; P L De Jager
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

8.  Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.

Authors:  N Evangelou; G C DeLuca; T Owens; M M Esiri
Journal:  Brain       Date:  2004-11-17       Impact factor: 13.501

9.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Authors:  Stephen Sawcer; Garrett Hellenthal; Matti Pirinen; Chris C A Spencer; Nikolaos A Patsopoulos; Loukas Moutsianas; Alexander Dilthey; Zhan Su; Colin Freeman; Sarah E Hunt; Sarah Edkins; Emma Gray; David R Booth; Simon C Potter; An Goris; Gavin Band; Annette Bang Oturai; Amy Strange; Janna Saarela; Céline Bellenguez; Bertrand Fontaine; Matthew Gillman; Bernhard Hemmer; Rhian Gwilliam; Frauke Zipp; Alagurevathi Jayakumar; Roland Martin; Stephen Leslie; Stanley Hawkins; Eleni Giannoulatou; Sandra D'alfonso; Hannah Blackburn; Filippo Martinelli Boneschi; Jennifer Liddle; Hanne F Harbo; Marc L Perez; Anne Spurkland; Matthew J Waller; Marcin P Mycko; Michelle Ricketts; Manuel Comabella; Naomi Hammond; Ingrid Kockum; Owen T McCann; Maria Ban; Pamela Whittaker; Anu Kemppinen; Paul Weston; Clive Hawkins; Sara Widaa; John Zajicek; Serge Dronov; Neil Robertson; Suzannah J Bumpstead; Lisa F Barcellos; Rathi Ravindrarajah; Roby Abraham; Lars Alfredsson; Kristin Ardlie; Cristin Aubin; Amie Baker; Katharine Baker; Sergio E Baranzini; Laura Bergamaschi; Roberto Bergamaschi; Allan Bernstein; Achim Berthele; Mike Boggild; Jonathan P Bradfield; David Brassat; Simon A Broadley; Dorothea Buck; Helmut Butzkueven; Ruggero Capra; William M Carroll; Paola Cavalla; Elisabeth G Celius; Sabine Cepok; Rosetta Chiavacci; Françoise Clerget-Darpoux; Katleen Clysters; Giancarlo Comi; Mark Cossburn; Isabelle Cournu-Rebeix; Mathew B Cox; Wendy Cozen; Bruce A C Cree; Anne H Cross; Daniele Cusi; Mark J Daly; Emma Davis; Paul I W de Bakker; Marc Debouverie; Marie Beatrice D'hooghe; Katherine Dixon; Rita Dobosi; Bénédicte Dubois; David Ellinghaus; Irina Elovaara; Federica Esposito; Claire Fontenille; Simon Foote; Andre Franke; Daniela Galimberti; Angelo Ghezzi; Joseph Glessner; Refujia Gomez; Olivier Gout; Colin Graham; Struan F A Grant; Franca Rosa Guerini; Hakon Hakonarson; Per Hall; Anders Hamsten; Hans-Peter Hartung; Rob N Heard; Simon Heath; Jeremy Hobart; Muna Hoshi; Carmen Infante-Duarte; Gillian Ingram; Wendy Ingram; Talat Islam; Maja Jagodic; Michael Kabesch; Allan G Kermode; Trevor J Kilpatrick; Cecilia Kim; Norman Klopp; Keijo Koivisto; Malin Larsson; Mark Lathrop; Jeannette S Lechner-Scott; Maurizio A Leone; Virpi Leppä; Ulrika Liljedahl; Izaura Lima Bomfim; Robin R Lincoln; Jenny Link; Jianjun Liu; Aslaug R Lorentzen; Sara Lupoli; Fabio Macciardi; Thomas Mack; Mark Marriott; Vittorio Martinelli; Deborah Mason; Jacob L McCauley; Frank Mentch; Inger-Lise Mero; Tania Mihalova; Xavier Montalban; John Mottershead; Kjell-Morten Myhr; Paola Naldi; William Ollier; Alison Page; Aarno Palotie; Jean Pelletier; Laura Piccio; Trevor Pickersgill; Fredrik Piehl; Susan Pobywajlo; Hong L Quach; Patricia P Ramsay; Mauri Reunanen; Richard Reynolds; John D Rioux; Mariaemma Rodegher; Sabine Roesner; Justin P Rubio; Ina-Maria Rückert; Marco Salvetti; Erika Salvi; Adam Santaniello; Catherine A Schaefer; Stefan Schreiber; Christian Schulze; Rodney J Scott; Finn Sellebjerg; Krzysztof W Selmaj; David Sexton; Ling Shen; Brigid Simms-Acuna; Sheila Skidmore; Patrick M A Sleiman; Cathrine Smestad; Per Soelberg Sørensen; Helle Bach Søndergaard; Jim Stankovich; Richard C Strange; Anna-Maija Sulonen; Emilie Sundqvist; Ann-Christine Syvänen; Francesca Taddeo; Bruce Taylor; Jenefer M Blackwell; Pentti Tienari; Elvira Bramon; Ayman Tourbah; Matthew A Brown; Ewa Tronczynska; Juan P Casas; Niall Tubridy; Aiden Corvin; Jane Vickery; Janusz Jankowski; Pablo Villoslada; Hugh S Markus; Kai Wang; Christopher G Mathew; James Wason; Colin N A Palmer; H-Erich Wichmann; Robert Plomin; Ernest Willoughby; Anna Rautanen; Juliane Winkelmann; Michael Wittig; Richard C Trembath; Jacqueline Yaouanq; Ananth C Viswanathan; Haitao Zhang; Nicholas W Wood; Rebecca Zuvich; Panos Deloukas; Cordelia Langford; Audrey Duncanson; Jorge R Oksenberg; Margaret A Pericak-Vance; Jonathan L Haines; Tomas Olsson; Jan Hillert; Adrian J Ivinson; Philip L De Jager; Leena Peltonen; Graeme J Stewart; David A Hafler; Stephen L Hauser; Gil McVean; Peter Donnelly; Alastair Compston
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  8 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Spaceflight alters expression of microRNA during T-cell activation.

Authors:  Millie Hughes-Fulford; Tammy T Chang; Emily M Martinez; Chai-Fei Li
Journal:  FASEB J       Date:  2015-08-14       Impact factor: 5.191

Review 3.  Future Brain and Spinal Cord Volumetric Imaging in the Clinic for Monitoring Treatment Response in MS.

Authors:  Tim Sinnecker; Cristina Granziera; Jens Wuerfel; Regina Schlaeger
Journal:  Curr Treat Options Neurol       Date:  2018-04-20       Impact factor: 3.598

4.  Combinations of susceptibility genes are associated with higher risk for multiple sclerosis and imply disease course specificity.

Authors:  Denis A Akkad; Alexandra Olischewsky; Franziska Reiner; Kerstin Hellwig; Sarika Esser; Jörg T Epplen; Tomaz Curk; Ralf Gold; Aiden Haghikia
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 5.  Translational utility of experimental autoimmune encephalomyelitis: recent developments.

Authors:  Andre Ortlieb Guerreiro-Cacais; Hannes Laaksonen; Sevasti Flytzani; Marie N'diaye; Tomas Olsson; Maja Jagodic
Journal:  J Inflamm Res       Date:  2015-11-13

6.  GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis.

Authors:  J P Hussman; A H Beecham; M Schmidt; E R Martin; J L McCauley; J M Vance; J L Haines; M A Pericak-Vance
Journal:  Genes Immun       Date:  2016-06-09       Impact factor: 2.676

Review 7.  Primary Progressive Multiple Sclerosis: Putting Together the Puzzle.

Authors:  Ahmed Abdelhak; Martin S Weber; Hayrettin Tumani
Journal:  Front Neurol       Date:  2017-05-31       Impact factor: 4.003

8.  Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis.

Authors:  Chiara Scapoli; Nicole Ziliotto; Barbara Lunghi; Erica Menegatti; Fabrizio Salvi; Paolo Zamboni; Marcello Baroni; Francesco Mascoli; Francesco Bernardi; Giovanna Marchetti
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.